Skip to Content

Preotact

Active Substance: parathyroid hormone (rDNA)
Common Name: parathyroid hormone (rDNA)
ATC Code: H05AA03
Marketing Authorisation Holder: NPS Pharma Holdings Limited
Active Substance: parathyroid hormone (rDNA)
Status: Withdrawn
Authorisation Date: 2006-04-24
Therapeutic Area: Osteoporosis, Postmenopausal
Pharmacotherapeutic Group: Calcium homeostasis

Therapeutic Indication

Treatment of osteoporosis in postmenopausal women at high risk of fractures (see section 5.1).

A significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated.

The marketing authorisation for Preotact has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide